Gabriele M Cerrone - Net Worth and Insider Trading

Gabriele M Cerrone Net Worth

The estimated net worth of Gabriele M Cerrone is at least $2 Million dollars as of 2024-06-05. Gabriele M Cerrone is the Director, 10% Owner of Accustem Sciences Inc and owns about 3,864,452 shares of Accustem Sciences Inc (ACUT) stock worth over $2 Million. Gabriele M Cerrone is also the Non-Executive Chairman, 10% Owner of OKYO Pharma Ltd and owns about 62,500 shares of OKYO Pharma Ltd (OKYO) stock worth over $90,000. Details can be seen in Gabriele M Cerrone's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gabriele M Cerrone has not made any transactions after 2022-12-30 and currently still holds the listed stock(s).

Transaction Summary of Gabriele M Cerrone

To

Gabriele M Cerrone Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gabriele M Cerrone owns 1 companies in total, including OKYO Pharma Ltd (OKYO) .

Click here to see the complete history of Gabriele M Cerrone’s form 4 insider trades.

Insider Ownership Summary of Gabriele M Cerrone

Ticker Comapny Transaction Date Type of Owner
OKYO OKYO Pharma Ltd 2022-05-19 director & 10 percent owner & Executive Chairman

Gabriele M Cerrone Latest Holdings Summary

Gabriele M Cerrone currently owns a total of 2 stocks. Among these stocks, Gabriele M Cerrone owns 3,864,452 shares of Accustem Sciences Inc (ACUT) as of December 30, 2022, with a value of $2 Million and a weighting of 94.86%. Gabriele M Cerrone also owns 62,500 shares of OKYO Pharma Ltd (OKYO) as of May 19, 2022, with a value of $90,000 and a weighting of 5.14%.

Latest Holdings of Gabriele M Cerrone

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACUT Accustem Sciences Inc 2022-12-30 3,864,452 0.43 1,661,714
OKYO OKYO Pharma Ltd 2022-05-19 62,500 1.44 90,000

Holding Weightings of Gabriele M Cerrone


Gabriele M Cerrone Form 4 Trading Tracker

According to the SEC Form 4 filings, Gabriele M Cerrone has made a total of 6 transactions in Accustem Sciences Inc (ACUT) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Accustem Sciences Inc is the acquisition of 5,000 shares on December 30, 2022, which cost Gabriele M Cerrone around $7,000.

According to the SEC Form 4 filings, Gabriele M Cerrone has made a total of 3 transactions in OKYO Pharma Ltd (OKYO) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in OKYO Pharma Ltd is the acquisition of 37,500 shares on May 19, 2022, which cost Gabriele M Cerrone around $150,000.

Insider Trading History of Gabriele M Cerrone

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gabriele M Cerrone Trading Performance

GuruFocus tracks the stock performance after each of Gabriele M Cerrone's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gabriele M Cerrone is -24.89%. GuruFocus also compares Gabriele M Cerrone's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gabriele M Cerrone within 3 months outperforms 2 times out of 9 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gabriele M Cerrone's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gabriele M Cerrone

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 9 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -23.8 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -19.16 LIMIT LIMIT LIMIT LIMIT LIMIT

Gabriele M Cerrone Ownership Network

Ownership Network List of Gabriele M Cerrone

No Data

Ownership Network Relation of Gabriele M Cerrone

Insider Network Chart

Gabriele M Cerrone Owned Company Details

What does OKYO Pharma Ltd do?

Who are the key executives at OKYO Pharma Ltd?

Gabriele M Cerrone is the director & 10 percent owner & Executive Chairman of OKYO Pharma Ltd. Other key executives at OKYO Pharma Ltd include director & Chief Executive Officer Gary S Jacob , and Chief Financial Officer Keeren Shah .

OKYO Pharma Ltd (OKYO) Insider Trades Summary

Over the past 18 months, Gabriele M Cerrone made no insider transaction in OKYO Pharma Ltd (OKYO). Other recent insider transactions involving OKYO Pharma Ltd (OKYO) include a net purchase of 16,670 shares made by John P Brancaccio ,

In summary, during the past 3 months, insiders sold 0 shares of OKYO Pharma Ltd (OKYO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of OKYO Pharma Ltd (OKYO) were sold and 16,670 shares were bought by its insiders, resulting in a net purchase of 16,670 shares.

OKYO Pharma Ltd (OKYO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

OKYO Pharma Ltd Insider Transactions

No Available Data

Gabriele M Cerrone Mailing Address

Above is the net worth, insider trading, and ownership report for Gabriele M Cerrone. You might contact Gabriele M Cerrone via mailing address: 265 East 66th Street, Suite 16g, New York Ny 10021.

Discussions on Gabriele M Cerrone

No discussions yet.